Donepezil Jubilant 10mg film-coated Tablets Malta - English - Medicines Authority

donepezil jubilant 10mg film-coated tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - donepezil hydrochloride - film-coated tablet - donepezil hydrochloride 10 mg - psychoanaleptics

Donepezil Jubilant 5 mg film-coated tablets Malta - English - Medicines Authority

donepezil jubilant 5 mg film-coated tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - film-coated tablet - donepezil hydrochloride 5 mg - psychoanaleptics

Donepezil Jubilant 10 mg film-coated tablets Malta - English - Medicines Authority

donepezil jubilant 10 mg film-coated tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - film-coated tablet - donepezil hydrochloride 10 mg - psychoanaleptics

Oxcarbazepine Jubilant 150mg film-coated Tablets Malta - English - Medicines Authority

oxcarbazepine jubilant 150mg film-coated tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - oxcarbazepine - film-coated tablet - oxcarbazepine 150 mg - antiepileptics

Oxcarbazepine Jubilant 300mg film-coated Tablets Malta - English - Medicines Authority

oxcarbazepine jubilant 300mg film-coated tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - oxcarbazepine - film-coated tablet - oxcarbazepine 300 mg - antiepileptics

Oxcarbazepine Jubilant 600mg film-coated Tablets Malta - English - Medicines Authority

oxcarbazepine jubilant 600mg film-coated tablets

jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - oxcarbazepine - film-coated tablet - oxcarbazepine 600 mg - antiepileptics

Spasmomen 40mg film-coated Tablets Malta - English - Medicines Authority

spasmomen 40mg film-coated tablets

a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - otilonium bromide - film-coated tablet - otilonium bromide 40 mg - drugs for functional gastrointestinal disorders

ONGLYZA saxagliptin (as hydrochloride) 2.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

onglyza saxagliptin (as hydrochloride) 2.5 mg film-coated tablet blister pack

astrazeneca pty ltd - saxagliptin, quantity: 2.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; lactose monohydrate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; indigo carmine aluminium lake; ethanol; shellac; sulfuric acid; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicines, when these together with diet and exercise, do not provide adequate glycaemic control (see clinical trials and precautions for available data on different add-on combination therapies).,initial combination: onglyza is indicated for use as initial combination therapy with metformin, in patients with type 2 diabetes mellitus, to improve glycaemic control as an adjunct to diet and exercise, when dual saxagliptin and metformin therapy is appropriate (i.e. high initial hba1c levels and poor prospects for response to monotherapy).

QTERN 5/10 saxagliptin (as hydrochloride) / dapagliflozin (as propanediol monohydrate) 5 mg / 10 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

qtern 5/10 saxagliptin (as hydrochloride) / dapagliflozin (as propanediol monohydrate) 5 mg / 10 mg film-coated tablet blister pack

astrazeneca pty ltd - dapagliflozin propanediol monohydrate, quantity: 12.3 mg (equivalent: dapagliflozin, qty 10 mg); saxagliptin, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose; croscarmellose sodium; silicon dioxide; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; indigo carmine aluminium lake; ethanol; shellac; sulfuric acid - qtern 5/10 is indicated as an adjunct to diet and exercise, in combination with metformin, to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin and dapagliflozin is appropriate.

ONGLYZA saxagliptin (as hydrochloride) 5 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

onglyza saxagliptin (as hydrochloride) 5 mg film coated tablet blister pack

astrazeneca pty ltd - saxagliptin, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; indigo carmine aluminium lake; ethanol; shellac; sulfuric acid; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; iron oxide red - add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicines, when these together with diet and exercise, do not provide adequate glycaemic control (see clinical trials and precautions for available data on different add-on combination therapies).,initial combination: onglyza is indicated for use as initial combination therapy with metformin, in patients with type 2 diabetes mellitus, to improve glycaemic control as an adjunct to diet and exercise, when dual saxagliptin and metformin therapy is appropriate (i.e. high initial hba1c levels and poor prospects for response to monotherapy).